A
|
GO:0045944 ~ positive regulation of transcription from RNA polymerase II promoter
|
1.84E-10
|
hsa05200:Pathways in cancer
|
3.42E-10
|
GO:0045429 ~ positive regulation of nitric oxide biosynthetic process
|
2.50E-10
|
hsa05205:Proteoglycans in cancer
|
4.86E-10
|
GO:0008284 ~ positive regulation of cell proliferation
|
1.07E-09
|
hsa00590:Arachidonic acid metabolism
|
6.48E-03
|
B
|
GO:0006367 ~ transcription initiation from RNA polymerase II promoter
|
1.92E-11
|
hsa04066:HIF-1 signaling pathway
|
7.71E-08
|
GO:0045429 ~ positive regulation of nitric oxide biosynthetic process
|
1.11E-10
|
hsa00590:Arachidonic acid metabolism
|
1.86E-03
|
GO:0048146 ~ positive regulation of fibroblast proliferation
|
3.81E-08
|
hsa04064:NF-kappa B signaling pathway
|
4.83E-02
|
C
|
GO:0005887 ~ integral component of plasma membrane
|
1.25E-07
|
hsa04080:Neuroactive ligand-receptor interaction
|
2.01E-06
|
GO:0005886 ~ plasma membrane
|
6.80E-06
|
hsa04726:Serotonergic synapse
|
5.14E-03
|
GO:0007268 ~ chemical synaptic transmission
|
1.53E-04
|
hsa04020:Calcium signaling pathway
|
1.30E-02
|
D
|
GO:0006805 ~ xenobiotic metabolic process
|
2.07E-07
|
hsa00982:Drug metabolism - cytochrome P450
|
1.06E-04
|
GO:0008202 ~ steroid metabolic process
|
3.39E-06
|
hsa00980:Metabolism of xenobiotics by cytochrome P450
|
1.36E-04
|
GO:0042908 ~ xenobiotic transport
|
9.81E-06
|
hsa00830:Retinol metabolism
|
3.65E-03
|